{"title":"Inv(16)和T(9;22)在慢性髓性白血病中罕见共存,表现为细胞危象","authors":"Aymen Abbas, Mutaz Kalas, E. Raidullah","doi":"10.23958/ijirms/vol08-i09/1747","DOIUrl":null,"url":null,"abstract":"Chronic myeloid leukemia (CML) is associated with BCR-ABL1 fusion gene located on chromosome 22 as a result of a t(9;22)(q34;q11.2) translocation in about 90% of the patients. Also, coexistence of the t(9;22) and inv(16) chromosomal aberrations is a rare occurrence that has been described in CML (mainly the myeloid blast phase [CML-BP]), de novo AML, and a few cases of therapy-related AML (t-AML). We describe a 22 years old male in primary blast crisis of CML as initial presentation with coexistence of the t(9;22) and inv(16). Majority of cases, in which these abnormalities coexist are CML-BP, which is typically characterized by an aggressive clinical course rapid disease progression and resistance to chemotherapy.","PeriodicalId":14008,"journal":{"name":"International Journal of Innovative Research in Medical Science","volume":"78 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rare Coexistence of Inv(16) and T(9;22) in Patient with Chronic Myeloid Leukaemia Presenting as Blast Crisis\",\"authors\":\"Aymen Abbas, Mutaz Kalas, E. Raidullah\",\"doi\":\"10.23958/ijirms/vol08-i09/1747\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic myeloid leukemia (CML) is associated with BCR-ABL1 fusion gene located on chromosome 22 as a result of a t(9;22)(q34;q11.2) translocation in about 90% of the patients. Also, coexistence of the t(9;22) and inv(16) chromosomal aberrations is a rare occurrence that has been described in CML (mainly the myeloid blast phase [CML-BP]), de novo AML, and a few cases of therapy-related AML (t-AML). We describe a 22 years old male in primary blast crisis of CML as initial presentation with coexistence of the t(9;22) and inv(16). Majority of cases, in which these abnormalities coexist are CML-BP, which is typically characterized by an aggressive clinical course rapid disease progression and resistance to chemotherapy.\",\"PeriodicalId\":14008,\"journal\":{\"name\":\"International Journal of Innovative Research in Medical Science\",\"volume\":\"78 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Innovative Research in Medical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23958/ijirms/vol08-i09/1747\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Innovative Research in Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23958/ijirms/vol08-i09/1747","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rare Coexistence of Inv(16) and T(9;22) in Patient with Chronic Myeloid Leukaemia Presenting as Blast Crisis
Chronic myeloid leukemia (CML) is associated with BCR-ABL1 fusion gene located on chromosome 22 as a result of a t(9;22)(q34;q11.2) translocation in about 90% of the patients. Also, coexistence of the t(9;22) and inv(16) chromosomal aberrations is a rare occurrence that has been described in CML (mainly the myeloid blast phase [CML-BP]), de novo AML, and a few cases of therapy-related AML (t-AML). We describe a 22 years old male in primary blast crisis of CML as initial presentation with coexistence of the t(9;22) and inv(16). Majority of cases, in which these abnormalities coexist are CML-BP, which is typically characterized by an aggressive clinical course rapid disease progression and resistance to chemotherapy.